Membrane marker studies with anti-T, anti-Ia (DR) and anti-myeloblast antisera in acute leukaemias
Lebacq, A.M.; Goffinet, P.; De Bruyere, M.; Rodhain, J.; Sokal, G.
European Journal of Cancer and Clinical Oncology 18(2): 147-153
1982
ISSN/ISBN: 0277-5379 PMID: 7047166 Document Number: 197052
Hetero-antisera reacting specifically with all cells of the T lineage, with Ia-like (DR) antigens or with myeloblasts were used as diagnostic aids in the classification of 64 acute leukemias . The anti-myeloblast proved particularly useful in discriminating early myeloblasts from atypical lymphoblasts and undifferentiated blasts.
Document emailed within 1 workday
Related Documents
Devaux, C.; Pierres, M. 1982: Clonal analysis of B and T cell responses to Ia antigens. III. Characterization of 12 xenogeneic anti-idiotypic antisera to A.TH-derived anti-I-Ak and anti-I-Ek monoclonal antibodies Journal of Immunology 128(2): 751-757Bringmann, P.; Rinke, J.; Appel, B.; Reuter, R.; Lührmann, R. 1983: Purification of sn RNPs U1, U2, U4, U5 and U6 with 2,2,7-trimethylguanosine-specific antibody and definition of their constituent proteins reacting with anti-Sm and anti-(U1) RNP antisera EMBO Journal 2(7): 1129-1135
Kano, S. 1999: Serological diagnosis of streptococcal infection (anti-streptolysin O; ASO, anti-streptokinase; ASK, anti-deoxyribonuclease B; ADNB, anti-hyaluronidase; AHD, anti-streptococcal polysaccharide; ASP) Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 107-116
Niermeiier, P.; Gips, C.H.; Huizenga, J.R.; Ringers, J.; Verkerk, S.; Houthuff, H.J.; Houwen, B.; Snijder, J.A.; Nielsen, J.O. 1978: IgM-anti-HBc as a marker of persistent and IgG-anti-HBc as a marker of past hepatitis B infection. a longitudinal study over 5 years Acta Hepato-Gastroenterologica 25(5): 360-364
Nakamura, H.; Kadokawa, T.; Nakatsuji, K.; Nakamura, K. 1970: Pharmacological studies of a new anti-inflammatory drug, 1-phenylsulfonyl-5,5-diphenylhydantoin (PC-796) in experimental animals. I. Anti-inflammatory, analgesic and anti-pyretic activity Arzneimittel-Forschung 20(8): 1032-1046
Førre, O.; Gaarder, P.I.; Natvig, J.B. 1977: VH subgroup restriction in human erythrocyte antibodies: Studies of anti-A, anti-B, and anti-Duffy antibodies Scandinavian Journal of Immunology 6(1-2): 149-156
Levy, M.; Gagnadoux, M.F.; Beziau, A.; Habib, R. 1978: Membranous glomerulonephritis associated with anti-tubular and anti-alveolar basement membrane antibodies Clinical Nephrology 10(4): 158-165
Diaz, J.I.; Valenzuela, R.; Gephardt, G.; Novick, A.; Tubbs, R.R. 1994: Anti-glomerular and anti-tubular basement membrane nephritis in a renal allograft recipient with Alport's syndrome Archives of Pathology and Laboratory Medicine 118(7): 728-731
Espinouse, D.; Touraine, J.L.; Schmitt, D.; Revol, L. 1980: Specific anti-hairy cell and anti-B cell antisera: characterization of surface antigens and origin of hairy cells Clinical and Experimental Immunology 39(3): 756-767
Kazimierska, E.; Górski, J. 1989: Anti-HBS, anti-CMV, and anti-HIV antibodies and HBS antigen in patients with hemophilia, malignant lymphomas, leukemias and multiple myeloma Acta Haematologica Polonica 20(2): 189-194
Zivković, V.; Stanković, A.; Cvetković, T.; Mitić, B.; Kostić, S.; Nedović, J.; Stamenković, B. 2014: Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus Srpski Arhiv Za Celokupno Lekarstvo 142(7-8): 431-436
Kumagai, T.; Kameko, M.; Kanai, M.; Maruyama, K. 1985: A study on autoantibodies including anti-nDNA, anti-RNP and anti-Sm antibody in various autoimmune diseases Rinsho Byori. Japanese Journal of Clinical Pathology 33(3): 293-297
Locht, H.; Pelck, R.; Manthorpe, R. 2008: Diagnostic and prognostic significance of measuring antibodies to alpha-fodrin compared to anti-Ro-52, anti-Ro-60, and anti-La in primary Sjögren's syndrome Journal of Rheumatology 35(5): 845-849
Perosa, F.; Scudeletti, M.; Imro, M.A.; Dammacco, F.; Luccarelli, G.; Indiveri, F. 1997: Anti-CD4 monoclonal antibody (mAb) and anti-idiotypic mAb to anti-CD4 in the therapy of autoimmune diseases Clinical and Experimental Rheumatology 15(2): 201-210
Tanaka, M. 2005: RA-related autoantibodies (anti-calpastatin, anti-gp130-RAPS, and anti-FRP antibodies) Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 7): 449-452
Ogutu, E.O.; Amayo, E.O.; Okoth, F.; Lule, G.N. 1990: The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS) East African Medical Journal 67(5): 355-358
Ogutu, E.O.; Amayo, E.O.; Okoth, F.; Lule, G.N. 1990: The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS) East African Medical Journal 67(5): 355-358
Kinoshita, M. 1990: Anti-Jo-1 antibody and anti-aminoacyl-tRNA synthetase antibody as a marker autoantibody for myositis Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 482-484
Birdsall, H.H.; Rossen, R.D. 1983: Characterization of anti-Fab' antibodies in human sera: identification of soluble immune complexes that contain hidden anti-KLH and blocking anti-immunoglobulins following immunization with keyhole limpet haemocyanin Clinical and Experimental Immunology 53(2): 497-504
Bemelmans, M.H.; Abramowicz, D.; Gouma, D.J.; Goldman, M.; Buurman, W.A. 1994: In vivo T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice. Effects of pentoxifylline, methylprednisolone, anti-TNF, and anti-IFN-gamma antibodies Journal of Immunology 153(2): 499-506